Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") - Preliminary findings

被引:148
|
作者
Reneman, L
Lavalaye, J
Schmand, B
de Wolff, FA
van den Brink, W
den Heeten, GJ
Booij, J
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, Grad Sch Neurosci, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Human Toxicol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Addict Res, NL-1105 AZ Amsterdam, Netherlands
[6] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands
[7] Leiden Univ, Med Ctr, Toxicol Lab, Leiden, Netherlands
关键词
D O I
10.1001/archpsyc.58.10.901
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Although the popular drug 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") has been shown to damage brain serotonin (5-HT) neurons in animals, the fate and functional consequences of 5-HT neurons after MDMA injury are not known in humans. We investigated the long-term effects of MDMA use on cortical 5-HT neurons in humans and memory function, because brain 5-HT has been implicated in memory function. Methods: Twenty-two recent MDMA users, 16 ex-MDMA users who had stopped using MDMA for more than 1 year, and 13 control subjects. The effects of MDMA use on cortical 5-HT neurons was studied by means of single-photon emission computed tomography with iodine 123-labeled 2 beta -carbomethoxy-3 beta-(4-iodophenyl) tropane ( [I-123] beta -CIT) by quantification of brain 5-HT transporter densities. Verbal memory performance was assessed with the Rey Auditory Verbal Learning Test. Results: Mean cortical [ I-121] beta -CIT-labeled 5-HT transporter density was significantly lower in recent MDMA users than in controls (1.17 vs 1.28 [-9%]) but not in ex-MDMA users (1.24 vs 1.28 [-3%]). Recent and ex-MDMA users recalled significantly fewer words than did controls on the immediate recall (47.0 and 48.0 vs 60.0, respectively; P = .001) as well as the delayed recall (9.8 and 10.1 vs 13.1, respectively; P = .003). Greater use of MDMA was associated with greater impairment in immediate verbal memory. However, memory performance was not associated with [I-123] beta -CIT binding to cortical 5-HT transporters or duration of abstinence from MDMA. Conclusion: The present study suggests that, while the neurotoxic effects of MDMA on 5-HT neurons in the human cortex may be reversible, the effects of MDMA on memory function may be long-lasting.
引用
收藏
页码:901 / 906
页数:6
相关论文
共 33 条
  • [1] Memory performance in abstinent 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users
    Groth-Marnat, Gary
    Howchar, Hennedy
    Marsh, Ali
    PERCEPTUAL AND MOTOR SKILLS, 2007, 104 (01) : 43 - 55
  • [2] Serotonin transporter dependent effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on the serotoninergic system and hippocampal cell proliferation in mice
    Renoir, T.
    Saurini, E.
    Hamon, M.
    Lanfumey, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S5 - S6
  • [3] In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") and Hallucinogen Users
    Erritzoe, David
    Frokjaer, Vibe G.
    Holst, Klaus K.
    Christoffersen, Maria
    Johansen, Sys S.
    Svarer, Claus
    Madsen, Jacob
    Rasmussen, Peter M.
    Ramsoy, Thomas
    Jernigan, Terry L.
    Knudsen, Gitte M.
    ARCHIVES OF GENERAL PSYCHIATRY, 2011, 68 (06) : 562 - 576
  • [4] SEROTONIN NEUROTOXICITY AFTER (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA ECSTASY) - A CONTROLLED-STUDY IN HUMANS
    MCCANN, UD
    RIDENOUR, A
    SHAHAM, Y
    RICAURTE, GA
    NEUROPSYCHOPHARMACOLOGY, 1994, 10 (02) : 129 - 138
  • [5] Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro
    Hayat, S
    Williams, RJ
    Rattray, M
    JOURNAL OF PSYCHOPHARMACOLOGY, 2006, 20 (02) : 257 - 263
  • [6] Inhibition of serotonin transporter activity and stimulation of dopamine uptake by putative metabolites of 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
    Jones, DC
    Lau, SS
    Monks, TJ
    FASEB JOURNAL, 2003, 17 (04): : A235 - A235
  • [7] Experimental studies on 3,4-methylenedioxymethamphetamine (MDMA, “ECSTASY”) and its potential to damage brain serotonin neurons
    George A. Ricaurte
    Una D. McCann
    Neurotoxicity Research, 2001, 3 : 85 - 99
  • [8] Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram
    Matthias E Liechti
    Christine Baumann
    Alex Gamma
    Franz X Vollenweider
    Neuropsychopharmacology, 2000, 22 : 513 - 521
  • [9] Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram
    Liechti, ME
    Baumann, C
    Gamma, A
    Vollenweider, FX
    NEUROPSYCHOPHARMACOLOGY, 2000, 22 (05) : 513 - 521
  • [10] Experimental studies on 3,4-methylenedioxymethamphetamine (MDMA, "ECSTASY") and its potential to damage brain serotonin neurons
    Ricaurte, George A.
    McCann, Una D.
    NEUROTOXICITY RESEARCH, 2001, 3 (01) : 85 - 99